J. Kell Williams, MD

Articles by J. Kell Williams, MD

A New Contraceptive Option: A Focus on the Transdermal Contraceptive System

ByAndrew M. Kaunitz, MD,Ronald T. Burkman, MD,Sandra Ann Carson, MD,Paula J. Hillard, MD,J. Kell Williams, MD

And my task for this afternoon is to review for you a new contraceptive option and what I’d like to do first is show you my disclosure statement and then I will go into the first part of discussion, talk about why I think there’s a need for this new contraception option and then go in much greater depth in discussing it.

Transitional Management: The Use of Oral Contraceptives in Perimenopause

ByAndrew M. Kaunitz, MD,Ronald T. Burkman, MD,Sandra Ann Carson, MD,Paula J. Hillard, MD,J. Kell Williams, MD,Andrew M. Kaunitz, MD,Ronald T. Burkman, MD,Andrew M. Kaunitz, MD,John A. Collins, MD,Maida B. Taylor, MD, MPh,Susan J. Wysocki, RNC, NP,Ronald T. Burkman, MD,Andrew M. Kaunitz, MD,John A. Collins, MD,Maida B. Taylor, MD, MPh,Susan J. Wysocki, RNC, NP,Ronald T. Burkman, MD,Andrew M. Kaunitz, MD,John A. Collins, MD,Maida B. Taylor, MD, MPh,Susan J. Wysocki, RNC, NP

A number of perimenopausal women and their health care providers choose to either decline or prematurely discontinue use of oral contraceptives (OCs), despite the availability of formulations that can prevent pregnancy and address perimenopausal symptoms. This lack of use is due to several factors.

Latest Updated Articles



Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us